drugset / Trial / NCT05616494
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This trial is a single-arm, multicenter clinical study to evaluate the efficacy and safety of Docetaxel for Injection (Albumin-bound) in patients with pancreatic cancer.
Timeline
- Start
- 2022-12-06
- Primary completion
- 2024-12-31
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |